Chih-Lin Lin, MD
Ren-Ai Branch, Taipei City Hospital
3
3
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Shih-Jer Hsu, MD
National Taiwan University Hosptial, Yun-Lin Branch
Shared therapeutic areas:
Worked with same sponsors:
Cheng-Chao Liang, MD
Far Eastern Memorial Hospital
Shared therapeutic areas:
Worked with same sponsors:
Ching-Sheng Hsu, MD
Buddhist Tzu Chi General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jia-Horng Kao, MD, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Chen-Hua Liu, MD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Ding-Shinn Chen, MD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Sheng-Shun Yang, MD, PhD
Taichung Veterans General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Huiwen Song
Sanming First Hospital
Shared therapeutic areas:
Qingrui Peng
Xiapu County Hospital
Shared therapeutic areas:
Xihua Fu
Guangzhou Panyu Central Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients
Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B
Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B
All 3 trials loaded